The B-raf gene is mutated in up to 66% of human malignant melanomas, and its protein product, BRAF kinase, is a key part of the RAS-RAF-MEK-ERK (MAPK) pathway of cancer cell proliferation [7]. Here, BRAF is linked to melanoma.